There were still 32,000 new cases of HIV in the U.S. in 2022. And about thousands of people still die annually from AIDS. HIV ...
Merck's two-drug HIV regimen doravirine/islatravir maintained viral suppression and matched Gilead's Biktarvy in Phase 3 ...
Leaders in HIV research highlighted the critical role of that research has played in advancing HIV science over the past 40 years. In a commentary in Nature Medicine, they explained how U.S.-funded ...
B/F/TAF shows lower ART switching rates and higher persistence among HIV patients, especially those with mental health or ...
Breast milk in women with HIV contains significantly lower levels of the essential amino acid tryptophan, researchers found. Tryptophan is important for an infant’s immune function, growth and brain ...
GSK raised its 2025 sales and earnings forecasts on Wednesday as its speciality HIV and cancer drugs posted double digit ...
The "miracle tool" HIV medicine lenacapavir will be sold in South Africa from as early as March or April 2026 according to ...
The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV strain.
Through a US$ 29 million grant, South Africa will receive enough medicine to provide HIV prevention to 450 000 people at high ...
Shares in the company rose on Wednesday morning as a result, lifting to their highest level for more than a year.
The NIH funding will help address a "traditional barrier" to health care, says Elizabeth Evans, professor of community health ...
A new UCLA study reveals that breast milk from women living with HIV contains significantly lower levels of tryptophan, an ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback